Angiotensin receptor-neprilysin inhibition (arni) therapy and reverse remodeling in heart failure with reduced ejection fraction

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1051-1053
Number of pages	3
Journal	JAMA - Journal of the American Medical Association
Volume	322
Issue number	11
DOIs	https://doi.org/10.1001/jama.2019.12662
State	Published - Sep 17 2019

ASJC Scopus subject areas

@article{8530c0d85a4343aab45baababb38d639,

title = "Angiotensin receptor-neprilysin inhibition (arni) therapy and reverse remodeling in heart failure with reduced ejection fraction",

author = "Drazner, {Mark H.}",

year = "2019",

month = sep,

day = "17",

doi = "10.1001/jama.2019.12662",

language = "English (US)",

volume = "322",

pages = "1051--1053",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "11",

}

TY - JOUR

T1 - Angiotensin receptor-neprilysin inhibition (arni) therapy and reverse remodeling in heart failure with reduced ejection fraction

AU - Drazner, Mark H.

PY - 2019/9/17

Y1 - 2019/9/17

UR - http://www.scopus.com/inward/record.url?scp=85071658553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071658553&partnerID=8YFLogxK

U2 - 10.1001/jama.2019.12662

DO - 10.1001/jama.2019.12662

M3 - Editorial

C2 - 31475298

AN - SCOPUS:85071658553

SN - 0098-7484

VL - 322

SP - 1051

EP - 1053

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 11

ER -